USA/France: Cooperative Research and Development Agreement Sanofi Cooperates with US Army in the Fight against Zika

Editor: Alexander Stark

Sanofi and its vaccines global business unit Sanofi Pasteur announced a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Research (WRAIR) on the co-development of a Zika vaccine candidate.

Related Companies

Sanofi Pasteur signs agreement for the development of a Zika vaccine.
Sanofi Pasteur signs agreement for the development of a Zika vaccine.
(Picture: Sanofii)

Paris/France – According to the terms of the agreement, Wrair will transfer its Zika purified inactivated virus (Zpiv) vaccine technology to Sanofi Pasteur, paving the way for a collaboration with the US government.

The agreement also includes Sanofi Pasteur's production of clinical material in compliance with current GMP (Good Manufacturing Practices) to support phase II testing, optimization of the upstream process to improve production yields, and characterization of the vaccine product. Sanofi Pasteur will also create a clinical development and regulatory strategy.

(ID:44161261)